Venous thrombosis: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Robert Badgett
(Started treatment)
imported>Howard C. Berkowitz
No edit summary
Line 1: Line 1:
In [[medicine]], '''superficial venous thrombosis''' is a form of [[embolism and thrombosis]].
'''Venous thrombosis''' is one of several diseases caused by inappropriate blood clots ([[thrombus|thrombi]]) in veins principally of the arms and legs. The major area of concern is [[deep venous thrombosis]], although there is also superficial venous thrombosis.
 
==Deep venous thrombosis==
==Prognosis==
{{main|Deep venous thrombosis}}
==Superficial venous thrombousis==
===Prognosis===
Superficial  venous thrombosis can be associated with [[deep venous thrombosis]] and an accompanying deep venous thrombosis occurring simultaneously or later.<ref name="pmid20157136">{{cite journal| author=Decousus H, Quéré I, Presles E, Becker F, Barrellier MT, Chanut M et al.| title=Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study. | journal=Ann Intern Med | year= 2010 | volume= 152 | issue= 4 | pages= 218-24 | pmid=20157136  
Superficial  venous thrombosis can be associated with [[deep venous thrombosis]] and an accompanying deep venous thrombosis occurring simultaneously or later.<ref name="pmid20157136">{{cite journal| author=Decousus H, Quéré I, Presles E, Becker F, Barrellier MT, Chanut M et al.| title=Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study. | journal=Ann Intern Med | year= 2010 | volume= 152 | issue= 4 | pages= 218-24 | pmid=20157136  
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&retmode=ref&cmd=prlinks&id=20157136 | doi=10.1059/0003-4819-152-4-201002160-00006 }} </ref>
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&retmode=ref&cmd=prlinks&id=20157136 | doi=10.1059/0003-4819-152-4-201002160-00006 }} </ref>


==Treatment==
===Treatment===
"Fondaparinux at a dose of 2.5 mg once a  day for 45 days was effective in the treatment of patients with acute,  symptomatic superficial-vein thrombosis of the legs and did not have serious  side effects" according to a [[randomized controlled  trial]]. <ref  name="pmid20860504">{{cite journal| author=Decousus H, Prandoni P, Mismetti  P, Bauersachs RM, Boda Z, Brenner B et al.| title=Fondaparinux for the treatment  of superficial-vein thrombosis in the legs. | journal=N Engl J Med | year= 2010  | volume= 363 | issue= 13 | pages= 1222-32 | pmid=20860504 |  doi=10.1056/NEJMoa0912072 }} </ref>
"Fondaparinux at a dose of 2.5 mg once a  day for 45 days was effective in the treatment of patients with acute,  symptomatic superficial-vein thrombosis of the legs and did not have serious  side effects" according to a [[randomized controlled  trial]]. <ref  name="pmid20860504">{{cite journal| author=Decousus H, Prandoni P, Mismetti  P, Bauersachs RM, Boda Z, Brenner B et al.| title=Fondaparinux for the treatment  of superficial-vein thrombosis in the legs. | journal=N Engl J Med | year= 2010  | volume= 363 | issue= 13 | pages= 1222-32 | pmid=20860504 |  doi=10.1056/NEJMoa0912072 }} </ref>


==References==
==References==
<references/>
<references/>

Revision as of 14:33, 14 October 2010

Venous thrombosis is one of several diseases caused by inappropriate blood clots (thrombi) in veins principally of the arms and legs. The major area of concern is deep venous thrombosis, although there is also superficial venous thrombosis.

Deep venous thrombosis

For more information, see: Deep venous thrombosis.

Superficial venous thrombousis

Prognosis

Superficial venous thrombosis can be associated with deep venous thrombosis and an accompanying deep venous thrombosis occurring simultaneously or later.[1]

Treatment

"Fondaparinux at a dose of 2.5 mg once a day for 45 days was effective in the treatment of patients with acute, symptomatic superficial-vein thrombosis of the legs and did not have serious side effects" according to a randomized controlled trial. [2]

References

  1. Decousus H, Quéré I, Presles E, Becker F, Barrellier MT, Chanut M et al. (2010). "Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study.". Ann Intern Med 152 (4): 218-24. DOI:10.1059/0003-4819-152-4-201002160-00006. PMID 20157136. Research Blogging.
  2. Decousus H, Prandoni P, Mismetti P, Bauersachs RM, Boda Z, Brenner B et al. (2010). "Fondaparinux for the treatment of superficial-vein thrombosis in the legs.". N Engl J Med 363 (13): 1222-32. DOI:10.1056/NEJMoa0912072. PMID 20860504. Research Blogging.